Canada markets open in 8 hours 20 minutes

Caladrius Biosciences, Inc. (CLBS)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.8900+0.0049 (+0.55%)
At close: 04:00PM EST
0.8900 0.00 (0.00%)
After hours: 06:42PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close0.8851
Open0.9000
Bid0.0000 x 2200
Ask0.0000 x 1200
Day's Range0.8700 - 0.9100
52 Week Range0.8200 - 4.8900
Volume297,841
Avg. Volume356,080
Market Cap53.204M
Beta (5Y Monthly)1.02
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
All
News
  • GlobeNewswire

    Caladrius Biosciences Provides Corporate Update and Reports 2021 Third Quarter Financial Results

    Company Reports Strong Cash Position as it Prepares to Initiate a CD34+ Cell Therapy Study in Diabetic Kidney Disease Conference call begins today at 4:30 p.m. Eastern time BASKING RIDGE, N.J., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of innovative therapies designed to treat or reverse disease, provides a corporate update and reports financial results for t

  • GlobeNewswire

    Caladrius Biosciences to Host Third Quarter 2021 Financial Results Conference Call on Thursday, November 4th at 4:30 p.m. Eastern Time

    BASKING RIDGE, N.J., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease, today announced that the Company will report its financial results for the three months ended September 30, 2021, on Thursday, November 4, 2021, at 4:30 p.m. (ET). To join the live conference call, please refer to the dial-in information provided

  • GlobeNewswire

    Caladrius Biosciences Announces Participation in Upcoming Conferences in October 2021

    BASKING RIDGE, N.J., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease, today announced its participation in several industry and investor events: UK Kidney Week® Virtual Conference (October 4-7, 2021)Location: VirtualSession Title: Discovering Effective New Targets for Therapy in Kidney DiseaseSession Date/Time: Mond